Regioselectivity and stereoselectivity of the metabolism of the chiral quinolizidine alkaloids sparteine and pachycarpine in the rat

References

• Bellet P. M. Contribution à l'etude de la lupanine et ses dérrivées. Annales Pharmaceutiques Françaises 1950; 8: 551
   PubMedGoogle Scholar
• Brandänge S., Lindblom L. The enzyme ‘aldehyde oxidase’ is an iminium oxidase. Reaction with nicotine Δ1(5)iminium ion. Biochemical and Biophysical Research Communications 1979; 91: 991
   PubMed Web of Science ®Google Scholar
• Chaudhuri A., Keller W. J. New mammalian metabolites of sparteine. Life Sciences 1990; 47: 319
   PubMed Web of Science ®Google Scholar
• Dayer P., Gasser R., Gut J., Kronbach T., Robertz G. M., Eichelbaum M., Meyer U. A. Characterisation of a common genetic defect of cytochrome P-450 function (Debrisoquinesparteine type polymorphism). Biochemical and Biophysical Research Communications 1984; 125: 374
   PubMed Web of Science ®Google Scholar
• Ebner T., Meese C. O. The use of deuterated analogues to study the mechanism of sparteine oxidation in man. Naunyn-Schmiedeberg's Archives of Pharmacology, Supplement 1988; 337: R121–482
   Google Scholar
• Ebner T., Eichelbaum M., Fischer P., Meese C. O. Über die stereospezifische Hydroxylierung von (+)-Spartein (Pachycarpin) in der Ratte. Archiv der Pharmazie 1989a; 332: 399
   Google Scholar
• Ebner T., Resell J., Fischer P., Meese C. O. Synthesis and spectroscopic stereospecificity assay of the deuterated quinolizidine alkaloids (2S)-[2H]- and (2R)-[2H]-sparteine. Journal of Labelled Compounds and Radiopharmaceuticah 1989b; 27: 485
   Web of Science ®Google Scholar
• Ebner T., Lackner H., Remberg G., Meese C. O. 2,3-Didehydrospartein. Liebigs Annalen der Chemie 1989c; 197
   Google Scholar
• Ebner T., Meese C. O., Fischer P., Eichelbaum M. The use of stable label isotope-high resolution NMR technique for metabolic studies: The metabolism of sparteine. European Journal of Pharmacology 1990a; 183: 1640
   Web of Science ®Google Scholar
• Ebner T., Meese C. O., Eichelbaum M. Stable isotope studies on the stereochemistry of the polymorphic oxidation of sparteine and debrisoquine in man. Chirality and Biological Activity, B. Holmstedt, H. Frank, B. Testa. Alan R. Liss, New York 1990b; 191
   Google Scholar
• Eichelbaum M., Spannbrucker N., Steincke B., Dengler H. J. Defective N-oxidation of sparteine in man: a new pharmacogenetic aspect. European Journal of Clinical Pharmacology 1979; 16: 183
   PubMed Web of Science ®Google Scholar
• Eichelbaum M., Reetz K. P., Schmidt E. K., Zekorn C. The genetic polymorphism of sparteine metabolism. Xenobiotica 1986; 16: 465
   PubMed Web of Science ®Google Scholar
• Erina E. V. Pharmacology of ganglionic transmission. Handbook of Experimental Pharmacology, D. A. Kharkevitch. Springer Verlag, Berlin, Heidelberg, New York 1960; 425–438
   Google Scholar
• Golebiewski W. M., Spenser I. D. Lactams of sparteine. Canadian Journal of Chemistry 1985; 63: 716
   Web of Science ®Google Scholar
• Guengerich F. P. Oxidation of sparteines. Evidence against the formation of N-oxides. Journal of Medicinal Chemistry 1984; 27: 1101
   PubMed Web of Science ®Google Scholar
• Ho B., Castagnoli N. Trapping of metabolically generated electrophilic species with cyanide ion: metabolism of 1-benzylpyrrolidine. Journal of Medicinal Chemistry 1980; 23: 133
   PubMed Web of Science ®Google Scholar
• Kobayashi S., Murray S., Watson D., Sesardic D., Davies D. S., Boobis A. R. The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is inverse of that in man. Biochemical Pharmacology 1989; 38: 2795
   PubMed Web of Science ®Google Scholar
• Lancaster D. L., Adio R. A., Tai K. K., Simooya O. O., Broadhead G. D., Tucker G. T., Lennard M. S. Inhibition of metroprolol metabolism by chloroquine and other antimalarial drugs. Journal of Pharmacy and Pharmacology 1990; 42: 267
   PubMed Web of Science ®Google Scholar
• Leonard N. D., Thomas P. D., Gash V. W. Structures and reactions of the dehydrosparteines and their salts. Journal of the American Chemical Society 1955; 77: 1552
   Web of Science ®Google Scholar
• Lowry O. H., Rosebrough N. J., Parr A. L., Randall R. J. Protein measurement with Folin-phenol-reagent. Journal of Biological Chemistry 1951; 193: 265
   PubMed Web of Science ®Google Scholar
• Meese C. O., Ebner T. Synthesis of 5-, 6-, and 7-deutero sparteines. Journal of Labelled Compounds and Radiopharmaceuticah 1988; 25: 329
   Web of Science ®Google Scholar
• Meese C. O., Fischer P. Tracing the human metabolism of stable isotope-labelled drugs by ex vivo NMR spectroscopy. A revision of S-carboxymethyl-L-cysteine biotransformation. Zeitschrift für Naturforschung 1990; 45c: 139–143
   Google Scholar
• Meese C. O., Specht D., Fischer P. Revision of S-carboxyrnethyl-L-cysteine metabolism by 13C-NMR spectroscopy. Fresenius Journal of Analytical Chemistry 1990; 337: 130
   Google Scholar
• Meyer U. A., Gut J., Kronbach T., Skoda C., Meier U. T., Catin T. The molecular mechanisms of two common polymorphisms of drug oxidation—evidence for functional changes in cytochrome P-450 isoenzymes catalyzing bufuralol and mephenytion oxidation. Xenobiotica 1986; 16: 449
   PubMed Web of Science ®Google Scholar
• Murphy P. J. Enzymatic oxidation of nicotine to nicotine Δ1(5)iminium ion. Journal of Biological Chemistry 1973; 248: 2796
   PubMed Web of Science ®Google Scholar
• Nebert D. W., Nelson D. R., Adesnik M., Coon M. J., Estabrook R. W., Gonzalez F. J., Guengerich F. P., Gunsalus I. C., Johnson E. F., Kemper B., Levin W., Phillips I. R., Sato R., Waterman M. R. The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci. DNA 1989; 8: 1
   PubMedGoogle Scholar
• Obach R. S., Vunakis H. V. Nicotinamide adenine dinucleotide (NAD)-dependent oxidation of nicotine Δ1(5)iminium ion to cotinine by rabbit liver microsomes. Biochemical Pharmacology 1990; 39: R1
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. Evidence for its haemoprotein nature. Journal of Biological Chemistry 1964; 239: 2370
   PubMed Web of Science ®Google Scholar
• Osikowska-Evers B. A., Eichelbaum M. A sensitive capillary GC assay for the determination of sparteine oxidation products in microsomal fractions of human liver. Life Sciences 1986; 38: 1775
   PubMed Web of Science ®Google Scholar
• Otton S. V., Crewe H. K., Lennard M. S., Tucker M. S., Woods H. F. Use of quinidine inhibition to define the role of sparteine/debrisoquine cytochrome P-450 in metoprolol oxidation by human liver microsomes. Journal of Pharmacological and Experimental Therapeutics 1988; 247: 242
   PubMed Web of Science ®Google Scholar
• Rink M., Grabowski K. Zur Kenntnis des 17-Hydroxysparteins. Archiv der Pharmazie 1956; 289: 695
   Google Scholar
• Ruenitz P. C., McLennon T. P., Sternson L. A. Biotransformation of azapetine to oxazapetine in rat and liver fractions. Drug Metabolism and Disposition 1979; 7: 204
   PubMed Web of Science ®Google Scholar
• Schwartz M. A., Kolis S. J. Oxidation of an amino carbinol by an NAP+-dependent microsomal dehydrogenase. Drug Metabolism and Disposition 1973; 1: 322
   PubMed Web of Science ®Google Scholar
• Siddoway L. A., Thompson K. A., McAllister C. B., Wang T., Wilkinson G. R., Roden D. M. Polymorphism of propafenone metabolism and disposition in man: clinical and pharmacokinetic consequences. Circulation 1987; 75: 785
   PubMed Web of Science ®Google Scholar
• Spiers C. J., Murray S., Boobis A. R., Seddon C. E., Davies D. S. Quinidine and the identification of drugs whose elimination is impaired in subjects classified as poor metabolisers of debrisoquine. British Journal of Clinical Pharmacology 1986; 22: 739
   PubMed Web of Science ®Google Scholar
• Whittlesea C. M. C., Lam L., Gorrod J. W. (1991) In vitro metabolism of some therapeutic alicyclic amine drugs by rabbit hepatic microsomes in the presence of 14C sodium cyanide. Presented at the 4th international symposium on the biological oxidation of nitrogen in organic molecules, Munich, 1989, Progress in Pharmacology and Clinical Pharmacology (in press)
   Google Scholar
• Wiewiorowski M., Edwards O. E., Bratek-Wiewiorowska M. D. Conformation of the C15 lupine alkaloids. Canadian Journal of Chemistry 1967; 45: 1447
   Web of Science ®Google Scholar
• Wilkinson L. Systat: the Systems for Statistics. Systat, Evanston, IL 1986
   Google Scholar
• Wolff T., Distelrath L. M., Worthington M. T., Groopman J. D., Hammons G. J., Kadlubar F. F., Proug R. A., Martin M. V., Guengerich F. P. Substrate specifity of human liver cytochrome P-450 debrisoquine 4-hydroxylase probed using immunochemical inhibition and chemical modeling. Cancer Research 1985; 45: 2116
   PubMed Web of Science ®Google Scholar